Free Trial

Lonza Group (LZAGY) Stock Forecast & Price Target

Lonza Group logo
$69.15 -0.98 (-1.40%)
As of 03:59 PM Eastern

Lonza Group - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
0
Buy
2

Based on 2 Wall Street analysts who have issued ratings for Lonza Group in the last 12 months, the stock has a consensus rating of "Strong Buy." Out of the 2 analysts, 2 have given a strong buy rating for LZAGY.

Consensus Price Target

N/A

Get the Latest News and Ratings for LZAGY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Lonza Group and its competitors.

Sign Up

LZAGY Analyst Ratings Over Time

TypeCurrent Forecast
8/5/24 to 8/5/25
1 Month Ago
7/6/24 to 7/6/25
3 Months Ago
5/7/24 to 5/7/25
1 Year Ago
8/6/23 to 8/5/24
Strong Buy
2 Strong Buy rating(s)
2 Strong Buy rating(s)
3 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
2 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Forecasted UpsideN/AN/AN/AN/A
Consensus Rating
Strong Buy
Strong Buy
Strong Buy
Buy

LZAGY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

LZAGY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Lonza Group Stock vs. The Competition

TypeLonza GroupMedical CompaniesS&P 500
Consensus Rating Score
4.00
2.81
2.53
Consensus RatingStrong BuyModerate BuyModerate Buy
Predicted UpsideN/A11,032.63% Upside13.60% Upside
News Sentiment Rating
Neutral News

See Recent LZAGY News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/27/2024Redburn Atlantic
5 of 5 stars
J. Clark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
10/9/2024The Goldman Sachs Group
3 of 5 stars
J. Quigley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
6/23/2024Berenberg Bank
2 of 5 stars
S. Bray
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
2/2/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
10/9/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 09:13 PM ET.


Should I Buy Lonza Group Stock? LZAGY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, August 3, 2025. Please send any questions or comments about these Lonza Group pros and cons to contact@marketbeat.com.

Lonza Group
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Lonza Group AG:

  • The current stock price is around $66.27, which may present a favorable entry point for potential investors looking for growth in the biopharmaceutical sector.
  • Lonza Group AG has shown a decrease in shares shorted recently, indicating a potential reduction in bearish sentiment among investors.
  • The company has a relatively low short percentage of float, suggesting that there is not a significant amount of negative speculation against its stock.
  • With an average daily volume of over 50,000 shares, Lonza Group AG demonstrates sufficient liquidity, making it easier for investors to enter and exit positions.
  • Lonza Group AG operates in a growing industry, which may provide opportunities for expansion and increased revenue in the future.

Lonza Group
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Lonza Group AG for these reasons:

  • The company has no outstanding shares reported, which may raise concerns about its market presence and investor confidence.
  • Institutional ownership is currently at 0%, indicating a lack of support from larger investment firms, which can be a red flag for retail investors.
  • Recent data shows a month-to-month change in shares shorted, which could suggest volatility and uncertainty in investor sentiment.
  • The company has not demonstrated significant performance over the past year, with a 52-week performance of 0, indicating stagnation.
  • With a very low float size, any significant buying or selling activity could lead to increased price volatility, which may deter risk-averse investors.

LZAGY Forecast - Frequently Asked Questions

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Lonza Group in the last year. There are currently 2 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "strong buy" LZAGY shares.

According to analysts, Lonza Group's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Analysts like Lonza Group more than other "medical" companies. The consensus rating for Lonza Group is Strong Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how LZAGY compares to other companies.


This page (OTCMKTS:LZAGY) was last updated on 8/5/2025 by MarketBeat.com Staff
From Our Partners